Correlation of vascular endothelial growth factor expression and microvessel density in Cervical Intraepithelial Neoplasia

Journal of the National Cancer Institute

Volumn 89, Issue 16, 1997, Pages 1212-1217

  Obermair, Andreas ^a   Bancher Todesca, Dagmar ^a   Bilgi, Selcuk ^a   Kaider, Alexandra ^b   Kohlberger, Petra ^a   Müllauer Ertl, Silvia ^a   Leodolter, Sepp ^a   Gitsch, Gerald ^a  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER GRADING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA;

EID: 0030839633     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.16.1212     Document Type: Article

References (34)

1. Weidner N. Intratumoral microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
2. Folkman J. Tumor angiogenesis. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA, editors. The molecular basis of cancer. Philadelphia: Saunders, 1995:206-32.
3. Melnyk O, Shuman MA, Kim KJ. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tuomr growth. Cancer Res 1996;56:921-4.
4. Teicher BA, Sotomayor EA, Huang ZD. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 1992;52:6702-4.
5. Brown PD, Giavazzi R. Matrix metalloproteinase inhihition: a review ot anti-tumour activity . Ann Oncol 1995;6:967-74.
6. Leung DW, Cachianes G, Kuang W, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
7. Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 1990;50:1774-8.
8. Brock TA, Dvorak HF, Senger DR. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 1991;138:213-21.
9. Ferrara N, Heinsohn H, Walder CE, Bunting S, Thomas GR. The regulation of blood vessel growth by vascular endothelial growth factor. Ann N Y Acad Sci 1995;752:246-56.
10. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39.
11. Ferenczy A, Winkler B. Cervical intraepithelial neoplasia and condyloma. In: Kurman RJ, editor. stein's pathology of the female genital tract. Hamburg: Springer, 1987.
12. Hinsemlann H. Der Nachweis der aktiven Ausgestaltung der Gefasse beim jungen Portiokarzinom als neues differentialdiagnostisches Hilfsmittel. Zentralbl Gynakol 1940;64:1810.
13. Stafl A, Mattingly RF. Angiogenesis of cervical neoplasia. Am J Obstet Gynecol 1975;121: 845-52.
14. Efron B, Tibshirani R. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
15. th ed. London: Charles Griffin. 1970.
16. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952;47:583-621.
17. Deen S, Ball RY. Basement membrane and extracellular interstitial matrix components in bladder neoplasia - evidence of angiogenesis. Histopathology 1994;25:475-81.
18. Brem S, Gullino PM, Medina D. Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science 1977; 195:880-2.
19. Brem SS, Jensen HM, Gullino PM. Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 1978;41:239-44.
20. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339:58-61.
21. Smith-McCune KK, Weidner N. Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 1994;54:800-4.
22. Guidi AJ, Abu-Jawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF, et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 1995;87: 237-45.
23. Soini Y, Pollanen R, Kemppainen S, Paakko P, Lehto VP. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical mtraepithelial lesions. APMIS 1969;104:183-90.
24. Abulafia O, Triest WE, Sherer DM. Angiogenesis in squamous cell carcinoma in situ and microinvasive carcinoma of the uterine cervix. Ohstet Gynecol 1996;88:927-32.
25. Zhang HT, Craft P, Scott PA, Ziche M, Weich HA, Harris AL, et al. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 1995;87:213-9.
26. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 1994;85:1045-9.
27. Takahashi Y, Kitudai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-8.
28. Obermair A, Kohlberger P, Bancher-Todesca D, Tempfer C, Sliutz G, Reinthaller A, et al. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression on prognosis in vulvar cancer. Gynecol Oncol 1996;63:204-9.
29. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991;174: 1275-8.
30. Qu-Hong, Nagy JA, Senger DR, Dvorak HF, Dvorak AM. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the albuminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem 1995;43:381-9.
31. Kataja V, Syrjanen S, Mantyjarvi R, Yliskoski M, Saarikoski S, Syrjanen K. Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis 1992;19:154-60.
32. Hellberg D, Nilsson S, Gad A, Hongxiu J, Fuju C, Syrjanen S, et al. Behavior of cervical intraepithelial neoplasia (CIN) associated with various human papillomavirus (HPV) types [published erratum appears in Arch Gynecol Obstet 1993;253:116]. Arch Gynecol Obstet 1993;252:119-28.
33. Meyskens FL Jr, Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 1994;86:539-43.
34. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149-53.